Feeling down? A systematic review of the gut microbiota in anxiety/depression and irritable bowel syndrome

被引:107
|
作者
Simpson, Carra A. [1 ,2 ,3 ]
Mu, Andre [4 ,5 ,6 ]
Haslam, Nick [1 ]
Schwartz, Orli S. [7 ,8 ]
Simmons, Julian G. [1 ,2 ,3 ]
机构
[1] Univ Melbourne, Melbourne Sch Psychol Sci, 12th Floor Redmond Barry Bldg, Parkville, Vic, Australia
[2] Univ Melbourne, Melbourne Neuropsychiat Ctr, Level 3,161 Barry St, Carlton, Vic 3053, Australia
[3] Melbourne Hlth, Parkville, Vic, Australia
[4] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia
[5] Univ Melbourne, Dept Microbiol & Immunol, Doherty Appl Microbial Genom, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia
[6] Univ Melbourne, Peter Doherty Inst Infect & Immun, Microbiol Diagnost Unit, Publ Hlth Lab, Melbourne, Vic, Australia
[7] Orygen, Parkville, Vic, Australia
[8] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic, Australia
关键词
Irritable bowel syndrome; Anxiety; Depression; Gut microbiota; Microbiome; Systematic review; ANXIETY; DEPRESSION; BRAIN; INFLAMMATION; IDENTIFICATION; DISORDERS; BEHAVIOR; PROFILE; STRESS; IMPACT;
D O I
10.1016/j.jad.2020.01.124
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Anxiety/depression and irritable bowel syndrome (IBS) are highly prevalent and burdensome conditions, whose co-occurrence is estimated between 44 and 84%. Shared gut microbiota alterations have been identified in these separate disorders relative to controls; however, studies have not adequately considered their comorbidity. This review set out to identify case-control studies comparing the gut microbiota in anxiety/depression, IBS, and both conditions comorbidly relative to each other and to controls, as well as gut microbiota investigations including measures of both IBS and anxiety/depression. Methods Four databases were systematically searched using comprehensive search terms (OVID Medline, Embase, PsycINFO, and PubMed), following PRISMA guidelines. Results Systematic review identified 17 studies (10 human, 7 animal). Most studies investigated the gut microbiota and anxiety/depression symptoms in IBS cohorts. Participants with IBS and high anxiety/depression symptoms had lower alpha diversity compared to controls and IBS-only cohorts. Machine learning and beta diversity distinguished between IBS participants with and without anxiety/depression by their gut microbiota. Comorbid IBS and anxiety/depression also had higher abundance of Proteobacteria, Prevotella/Prevotellaceae, Bacteroides and lower Lachnospiraceae relative to controls. Limitations A large number of gut microbiota estimation methods and statistical techniques were utilized; therefore, meta-analysis was not possible. Conclusions Well-designed case-control and longitudinal studies are required to disentangle whether the gut microbiota is predicted as a continuum of gastrointestinal and anxiety/depression symptom severity, or whether reported dysbiosis is unique to IBS and anxiety/depression comorbidity. These findings may inform the development of targeted treatment through the gut microbiota for individuals with both anxiety/depression and IBS.
引用
收藏
页码:429 / 446
页数:18
相关论文
共 50 条
  • [31] Dysfunctional Cognitions, Anxiety and Depression in Irritable Bowel Syndrome
    Thijssen, Annemieke Y.
    Jonkers, Dorothea M. A. E.
    Leue, Carsten
    van der Veek, Patrick P. J.
    Vidakovic-Vukic, Michelle
    van Rood, Yanda R.
    Clemens, Cornelis H. M.
    Masclee, Ad A. M.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (10) : E236 - E241
  • [32] ROLE OF GUT MICROBIOTA IN SYMPTOM EPISODES OF IRRITABLE BOWEL SYNDROME
    Mohan, Vidhyalakshmi
    Sanchez, Maria Ines Pinto
    Nardelli, Andrea
    Magee, Megan
    Borojevic, Rajka
    De Palma, Giada
    Mckibbin, Philip Britz
    Collins, Stephen M.
    Bercik, Premysl
    GASTROENTEROLOGY, 2023, 164 (06) : S1057 - S1057
  • [33] Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
    Zarina Mamieva
    Elena Poluektova
    Valery Svistushkin
    Vasily Sobolev
    Oleg Shifrin
    Francisco Guarner
    Vladimir Ivashkin
    World Journal of Gastroenterology, 2022, 28 (12) : 1204 - 1219
  • [34] Longitudinal Changes in Gut Microbiota in Patients With Irritable Bowel Syndrome
    Ward, Tonya L.
    Montassier, Emmanuel
    Lekatz, Heather
    Schmidt, Bradley
    Camilleri, Michael
    Hillmann, Benjamin M.
    Grover, Madhusudan
    Farrugia, Gianrico
    Knights, Dan
    Kashyap, Purna C.
    GASTROENTEROLOGY, 2016, 150 (04) : S64 - S64
  • [35] Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome
    Harris, Lucinda A.
    Baffy, Noemi
    POSTGRADUATE MEDICINE, 2017, 129 (08) : 872 - 888
  • [36] Functional dysbiosis of the gut microbiota in childhood irritable bowel syndrome
    Cone, S.
    Larkin, G.
    Poulton, C.
    Wemheuer, B.
    Thomas, T.
    Lemberg, D.
    Gupta, N.
    Leach, S. T.
    Coffey, M. J.
    Ooi, C. Y.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 144 - 145
  • [37] Irritable bowel syndrome: Shifting the focus toward the gut microbiota
    Shanahan, Fergus
    GASTROENTEROLOGY, 2007, 133 (01) : 340 - 342
  • [38] Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
    Mamieva, Zarina
    Poluektova, Elena
    Svistushkin, Valery
    Sobolev, Vasily
    Shifrin, Oleg
    Guarner, Francisco
    Ivashkin, Vladimir
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (12) : 1204 - 1219
  • [39] Gut Microbiota-Based Therapies for Irritable Bowel Syndrome
    Stern, Emily K.
    Brenner, Darren M.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2018, 9
  • [40] Irritable bowel syndrome: a gut microbiota-related disorder?
    Bhattarai, Yogesh
    Pedrogo, David A. Muniz
    Kashyap, Purna C.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2017, 312 (01): : G52 - G62